Seikagaku grants Ono rights to co-develop and market SI-613 in Japan

Seikagaku Corp. (Tokyo:4548) granted Ono Pharmaceutical Co. Ltd. (Tokyo:4528) rights to co-develop and exclusive rights to market SI-613 in Japan. Seikagaku will receive ¥2 billion ($18.2 million) u...